promoted as being less allergenic than animal insulins, nevertheless carry a risk of allergic reactions. To my knowledge, this is the first reported case of a generalised allergic reaction to human insulin in which reactions to highly purified monocomponent bovine and porcine insulins did not also occur.
Is there a link between iritis and diabetic autonomic neuropathy?
The strong association reported between iritis and autonomic neuropathy in insulin dependent diabetics has been used to support the hypothesis that damage to the autonomic nervous system is immunologically mediated. 'The high prevalence of iritis found in diabetics in that study ran counter to our own clinical experience, and we therefore investigated the prevalence of the condition in patients attending the diabetic department of this hospital.
Patients, methods, and results
Tests of autonomic function2 had been performed on 385 diabetics over three years. All the diabetics, except 17 known to have died, were sent a questionnaire to elicit the relative prevalence of iritis in the groups with and without autonomic neuropathy. The questionnaire asked about painful eye conditions requiring medical consultation. We followed up a positive response by contacting the ophthalmologist or general practitioner who had seen the patient and by reviewing the medical records. We also examined the ophthalmological and diabetic records of patients who had died to ascertain whether they had had iritis. were unable to make a diagnosis. The records of patients who had died showed one case of iritis, which had probably been caused by exposure to ultraviolet light during welding. The table summarises the results. Even when the two patients without definite diagnoses and the two patients with recognised causes of their iritis were included the prevalence of iritis in the group with autonomic neuropathy was less than 4%. This was not significantly higher than that in the group with normal results of tests of autonomic function (p=O 13, Fisher's exact test).
Numbers of diabetics with iritis
In the original report 47 diabetics aged 40 or less, all insulin dependent, had autonomic neuropathy as defined by a heart rate variability less than 10; 14 gave a history of iritis.' We identified 28 patients in our sample who fulfilled exactly these criteria; only one gave a history of iritis.
Comment
Iritis was strikingly less common in our patients with autonomic neuropathy than in those described by Guy et al.' This was true even when the analysis was confined to patients who met the same criteria of age, insulin dependence, and abnormality of heart rate variation. We did not find iritis to be significantly more prevalent in patients with autonomic neuropathy than in patients with normal autonomic function, but the uncertainty surrounding the estimate of the odds ratio, calculated using cases of definite iritis without recognised cause (odds ratio=2, 95% confidence limits 0 2, 22), means that our data do not exclude an association between the two conditions.
Unusual patients tend to be referred to specialised clinics.3 Perhaps the reputation of Guy et al for research into diabetic neuropathy led them to study an atypical group of patients. Our failure to replicate their finding, in a large sample of patients, of a high prevalence of iritis in diabetics with autonomic neuropathy must reduce the strength of their evidence for an immune pathogenesis for diabetic autonomic neuropathy.
We are grateful to Drs L Duncan, B F Clarke, and A Adams for allowing us to study their patients and to Kate Henderson and Carol O'Neill for help in collecting the data.
Effects of indomethacin and sulindac on blood pressure of hypertensive patients Some studies,' 2 but not others,' have shown a pressor effect ofindomethacin in patients treated for hypertension. Sulindac selectively inhibits extrarenal synthesis of prostaglandin and may not, therefore, antagonise the action of antihypertensive drugs.4" In an observer blind study we compared the effects of indomethacin and sulindac on blood pressure and symptoms in hypertensive patients who needed treatment with a non-steroidal antiinflammatory drug.
Patients, methods, and results
Twenty one patients with hypertension and coexisting joint disorders requiring treatment with a non-steroidal anti-inflammatory drug consented to the study, which was approved by the hospital ethics committee. They comprised 12 women and nine men (mean age 62 (range 40-76), mean weight 80 (56-108) kg). The antihypertensive drugs taken were kept constant throughout the study. Mean blood pressure on entry to the study was 147/95 mm Hg lying and 135/98 mm Hg standing. The open crossover study, with three phases, compared indomethacin (50 mg twice daily), sulindac (200 mg twice daily), and paracetamol (1 g four times daily); the order of treatments was varied using Williams squares. Phases of treatment lasted six weeks unless they had to be shortened because of side effects or unsatisfactory relief of symptoms. There were no washout intervals. Paracetamol was used instead of placebo because all patients required treatment for symptoms. Blood pressure, body weight, scores for pain and stiffness (10 
